InsiderTrades.com logo
This Apple-like Innovator is Revolutionizing Healthcare
From Wall Street Star   |   Ad
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
Click here to learn more about the booming eHealth industry

JSPR Insider Trading

Insider Ownership Percentage: 3.90%
Insider Buying (Last 12 Months): $4,544,800.00
Insider Selling (Last 12 Months): $45,502.00

Jasper Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Jasper Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Jasper Therapeutics Share Price & Price History

Current Price: $22.03
Price Change: ▼ Price Decrease of -0.08 (-0.36%)
As of 04/24/2024 01:00 AM ET

This chart shows the closing price history over time for JSPR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
From Traders Agency   |   Ad
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Click here now for the full details of this stock that’s set to rocket in the AI revolution…

Jasper Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/12/2024Jeetinder Singh MahalCOOSell900$26.44$23,796.0025,009View SEC Filing Icon  
2/8/2024Velan Capital Investment ManagMajor ShareholderBuy350,000$12.95$4,532,500.001,188,500View SEC Filing Icon  
11/20/2023Thomas G WiggansDirectorBuy1,000$6.30$6,300.003,000View SEC Filing Icon  
11/16/2023Thomas G WiggansDirectorBuy1,000$6.00$6,000.001,000View SEC Filing Icon  
10/13/2023William LisDirectorSell796$8.50$6,766.005,352View SEC Filing Icon  
6/13/2023Jeetinder Singh MahalInsiderSell900$16.60$14,940.0028,722View SEC Filing Icon  
4/14/2023Anna Louise FrenchDirectorSell700$14.80$10,360.002,375View SEC Filing Icon  
1/27/2023Carlyle Group Inc.Major ShareholderBuy313,333$15.00$4,699,995.00876,189View SEC Filing Icon  
1/25/2023Holding Ltd RocheMajor ShareholderSell7,500$18.90$141,750.00454,960View SEC Filing Icon  
6/27/2022William LisDirectorSell2,474$20.80$51,459.204,048View SEC Filing Icon  
6/24/2022William LisDirectorSell2,474$20.20$49,974.806,522View SEC Filing Icon  
See Full Table
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
From Traders Agency   |   Ad
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Click here now for the full details of this stock that’s set to rocket in the AI revolution…

SEC Filings (Institutional Ownership Changes) for Jasper Therapeutics (NASDAQ:JSPR)

79.85% of Jasper Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at JSPR by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Jasper Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/18/2024Kingdon Capital Management L.L.C.3,540,000$2.79M0.3%+16.4%31.720%Search for SEC Filing on Google Icon
2/15/2024Opaleye Management Inc.3,985,340$3.14M0.8%N/A35.717%Search for SEC Filing on Google Icon
2/7/2024Ieq Capital LLC54,500$43K0.0%N/A0.488%Search for SEC Filing on Google Icon
2/7/2024Monaco Asset Management SAM249,563$0.20M0.1%N/A2.236%Search for SEC Filing on Google Icon
2/5/2024Fernwood Investment Management LLC494,706$0.39M0.1%+8.8%4.433%Search for SEC Filing on Google Icon
11/13/2023Mariner LLC652,749$0.46M0.0%-8.7%0.589%Search for SEC Filing on Google Icon
11/9/2023Cowen AND Company LLC200,393$0.14M0.0%N/A0.181%Search for SEC Filing on Google Icon
11/8/2023Forefront Analytics LLC110,792$78K0.0%+59.7%0.100%Search for SEC Filing on Google Icon
10/30/2023Summit Trail Advisors LLC65,000$46K0.0%N/A0.059%Search for SEC Filing on Google Icon
8/15/2023Sphera Funds Management LTD.4,274,008$5.86M0.9%+5.7%3.874%Search for SEC Filing on Google Icon
8/14/2023Jefferies Financial Group Inc.489,884$0.67M0.0%N/A0.444%Search for SEC Filing on Google Icon
6/1/2023Prelude Capital Management LLC54,500$99K0.0%N/A0.049%Search for SEC Filing on Google Icon
5/16/2023Ally Bridge Group NY LLC2,517,232$4.56M6.0%N/A2.301%Search for SEC Filing on Google Icon
5/16/2023BVF Inc. IL9,900,000$17.92M0.7%N/A9.051%Search for SEC Filing on Google Icon
5/15/2023Affinity Asset Advisors LLC476,948$0.86M0.3%N/A0.436%Search for SEC Filing on Google Icon
5/15/2023Kingdon Capital Management L.L.C.3,040,000$5.50M1.0%+463.0%2.779%Search for SEC Filing on Google Icon
5/15/2023RTW Investments LP2,329,809$4.22M0.1%N/A2.130%Search for SEC Filing on Google Icon
5/12/2023Forefront Analytics LLC30,290$55K0.0%-73.4%0.028%Search for SEC Filing on Google Icon
5/5/2023Carlyle Group Inc.8,761,891$15.77M0.5%N/A8.011%Search for SEC Filing on Google Icon
5/3/2023Jump Financial LLC33,074$60K0.0%N/A0.030%Search for SEC Filing on Google Icon
4/25/2023Qiming U.S. Ventures Management LLC8,519,648$15.42M18.7%+45.6%7.789%Search for SEC Filing on Google Icon
2/13/2023Forefront Analytics LLC114,000$55K0.0%-4.8%0.300%Search for SEC Filing on Google Icon
2/7/2023Fernwood Investment Management LLC454,706$0.22M0.1%+53.1%1.197%Search for SEC Filing on Google Icon
11/14/2022Forefront Analytics LLC119,800$94K0.1%+246.0%0.327%Search for SEC Filing on Google Icon
11/9/2022Fernwood Investment Management LLC297,080$0.23M0.1%N/A0.810%Search for SEC Filing on Google Icon
5/10/2022Sectoral Asset Management Inc.675,000$2.40M0.4%N/A1.782%Search for SEC Filing on Google Icon
5/9/2022Forefront Analytics LLC32,550$0.12M0.0%N/A0.086%Search for SEC Filing on Google Icon
4/27/2022Vahanian & Associates Financial Planning Inc.10,000$36K0.1%-60.0%0.026%Search for SEC Filing on Google Icon
2/15/2022Kingdon Capital Management L.L.C.540,000$4.24M0.5%N/A1.427%Search for SEC Filing on Google Icon
2/2/2022Grace Capital218,110$1.71M1.0%N/A0.576%Search for SEC Filing on Google Icon
1/28/2022Vahanian & Associates Financial Planning Inc.25,000$0.20M0.2%N/A0.066%Search for SEC Filing on Google Icon
11/16/2021Citadel Advisors LLC3,005,035$29.22M0.0%N/A8.228%Search for SEC Filing on Google Icon
11/15/2021Tudor Investment Corp Et Al20,000$0.21M0.0%N/A0.055%Search for SEC Filing on Google Icon
11/15/2021Abingworth LLP5,628,558$58.03M13.2%N/A15.412%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Jasper Therapeutics logo
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of therapeutic agents for diseases, such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndrome, and novel conditioning regimens for stem cell transplantation and ex-vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company's lead product candidate is briquilimab, which is in clinical development as a novel therapeutic antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is headquartered in Redwood City, California.
Read More on Jasper Therapeutics

Today's Range

Now: $22.03
Low: $21.40
High: $22.55

50 Day Range

MA: $24.82
Low: $17.48
High: $30.00

52 Week Range

Now: $22.03
Low: $4.00
High: $31.01

Volume

44,701 shs

Average Volume

76,015 shs

Market Capitalization

$331.77 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.22

Who are the company insiders with the largest holdings of Jasper Therapeutics?

Jasper Therapeutics' top insider investors include:
  1. Velan Capital Investment Manag (Major Shareholder)
  2. Carlyle Group Inc (Major Shareholder)
  3. Holding Ltd Roche (Major Shareholder)
  4. Jeetinder Singh Mahal (Insider)
  5. Jeetinder Singh Mahal (COO)
  6. William Lis (Director)
  7. Thomas G Wiggans (Director)
  8. Anna Louise French (Director)
Learn More about top insider investors at Jasper Therapeutics.
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
From Traders Agency   |   Ad
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Click here now for the full details of this stock that’s set to rocket in the AI revolution…